Recent news on Levemir

Levemir use extended  -  Apr 26, 2007
Healthcare RepublicThe licence for Levemir (insulin detemir) has been extended to include use in combination with oral hypoglycaemic agents in the treatment of diabetes.

Insulin therapy for diabetes  -  May 16, 2007
Chennai Online,Humulin U is a crystalline suspension with zinc of Humulin while Lantus and Levemir are engineered analogs. The onset time is 4-6 hours for Humulin U and

Novo Nordisk Says Profit Rises 41% on Insulin Sales (Update5)  -  May 2, 2007
BloombergThe switch among diabetics to insulin analogues such as Novo Nordisk's 24-hour treatment Levemir boosted profit growth. The analogues, which are genetically

Novo Nordisk sees continuing market growth for modern insulin  -  May 2, 2007
Forbes,Sales of Levemir in the US will be supported by the recruitment of 700 new sales representatives, which is expected to be finalized during the first half of

Nearly Five Decades With Type 1  -  Apr 26, 2007
Diabetes Health (press release),Resisting the pump, I'm on insulin injections: 6 pm 4 units Levemir; 6 am (breakfast) 3.5 units Humalog; lunch 2 units Humalog; and dinner 2 units Humalog.

Fighting back  -  May 1, 2007
Auburn Citizen,In addition to an Animas insulin pump table, a Novo Nordisk table introduced attendees to the company's newest insulin injector, the Levemir FlexPen.

Levemir use extended  -  26 Apr 2007
Healthcare RepublicThe licence for Levemir (insulin detemir) has been extended to include use in combination with oral hypoglycaemic agents in the treatment of diabetes.

New Data Confirm That Use Of Levemir® Can Limit Weight Gain  -  Apr 23, 2007
Medical News Today (press release),The PREDICTIVE™ study is examining patient outcomes when Levemir® a long-acting modern insulin is used in the everyday clinical setting.

Standard Long-Acting Insulin As Good As Newer Medications  -  Apr 24, 2007
eMaxHealth.com,Newer drugs, insulin analogues such as insulin glargine (trade name Lantus) and insulin detemir (Levemir), have been marketed as an improvement over NPH.

New Data Confirm That Use of Levemir Can Limit Weight Gain  -  Apr 3, 2007
PipelineReview.com (press release),In the European cohort of PREDICTIVE(TM), a total of 20531 people with type 1 and type 2 diabetes from 11 countries were prescribed Levemir(R) and followed

Novo Nordisk says study confirms diabetes treatment Levemir limits ...  -  Apr 3, 2007
ABCmoney.co.uk,COPENHAGEN (AFX) - Novo Nordisk said a new study confirms that its diabetes treatment Levemir limits weight gain in patients. The study, named PREDICTIVE,

Older Insulin Keeps Up with New  -  Apr 18, 2007
Ivanhoe,While NPH was found safe and effective, however, the authors of the review did find some evidence that Levemir may be better at warding off low blood sugar

New, Old Insulin Drugs Equally Good  -  Apr 18, 2007
WebMDTogether, they compared an older insulin treatment called NPH to two newer, long-acting insulin treatments: Levemir (insulin detemir) and Lantus (insulin

Traditional Insulin Compares Well Against Analogs  -  Apr 18, 2007
MedPage Today,Neither insulin glargine (Lantus) nor insulin detemir (Levemir) were superior to NPH (neutral protamine Hagedorn, or isophane) insulin at protecting against

Novo Nordisk upgraded to "outperform"  -  Apr 17, 2007
newratings.comThe commercial potential of Novo Nordisk’s pipeline product, liraglutide, and the Levemir drug is higher than estimated by the markets, the analyst believes

Danish shares close higher led by ALK Abello UPDATE  -  Apr 3, 2007
ABCmoney.co.uk,Novo Nordisk added 8.00 dkr to 511.00 after the group said a new study confirms that its diabetes treatment Levemir limits weight gain in patients.

Fresh hope for obesity cure from early trials of diabetic treatment  -  Apr 4, 2007
Business Online,This comes in the same week as Novo Nordisk announced trials of another of its diabetes drugs, Levemir, which shows that it limits weight gain in patients.

A Leading Pediatric Endocrinologist Talks About Kids  -  Apr 13, 2007
Diabetes Health (press release),...use multiple meal-time bolus doses of fast-acting analogs (Humalog, Novolog, Apidra) coupled with a basal insulin–either Lantus or Levemir–twice a day.

The drug Exubera looks like an expensive flop for Pfizer  -  Apr 10, 2007
International Herald Tribune,In the last two years, three new diabetes medicines have reached the market - Januvia, Byetta and Symlin - as well as Levemir, a longer-acting version of

Healthy Shot For Your Portfolio  -  Apr 4, 2007
Forbes,Products include NovoLog, Levemir and InnoLet. The company also has strong market shares in treatments for bleeding disorders and growth hormone deficiency.

Danish shares close slightly higher led by AP Moller UPDATE  -  Apr 4, 2007
Forbes,...to Berlingske Business, opinion polls show medical doctors in the US prefer competitor Sanofi-Aventis' diabetes drug Lantus to Novo Nordisk's Levemir.

Danish shares slightly higher mid-morning, led by Vestas Wind and ...  -  Apr 4, 2007
Forbes,...polls show medical doctors in the US prefer competitor Sanofi-Aventis (nyse: SNY - news - people )' diabetes drug Lantus to Novo Nordisk's Levemir.

Lilly still breathing in inhaler pursuit  -  Mar 31, 2007
Indianapolis Business Journal,Novo Nordisk launched an equivalent of Lantus, called Levemir. But Lilly has not been able to follow suit. Lilly is doing well in other areas of diabetes

Levemir® Approved In Europe For Use In Combination With Oral ...  -  Mar 12, 2007
Medical News Today (press release),Novo Nordisk today announced that the European Commission has approved Levemir® (insulin detemir) for once-daily use in combination with oral antidiabetic

Levemir Approved in Europe for Use in Combination with Oral ...  -  Mar 1, 2007
PharmaLive.com (press release),COPENHAGEN, March 1, 2007-Novo Nordisk today announced that the European Commission has approved Levemir® (insulin detemir) for once-daily use in

EU approves Novo Nordisk's Levemir for use with oral anti-diabetic ...  -  Mar 1, 2007
ABCmoney.co.uk,COPENHAGEN (AFX) - Novo Nordisk AS said the European Commission has approved its insulin analogue Levemir for once-daily use in combination with oral

How to catch an insulin-doping athlete  -  Mar 8, 2007
Chemistry World,...the urine samples from the diabetic patients treated with recombinant human insulin or Levemir, two other commercially available long acting insulins.

Sector Snap: European Drugmakers Mixed  -  Mar 22, 2007
Forbes,The analyst also pinned hopes on the company shoring up its diabetes franchise with the pipeline drugs Liraglutide and Levemir.

Canadian Internet Pharmacy Sales to the United States Down 50% in 2006  -  Mar 21, 2007
PharmaLive.com (press release),They are diabetes medication Levemir (Novo Nordisk) with $12.3 million, Gardasil for the human papillomavirus (Merck Frosst) with $1.9 million and Sutent

PBS must ease pain  -  Mar 5, 2007
The Gold Coast Bulletin,These include drugs such as Herceptin for early breast cancers at a cost of $470 million over the next four years, Lantus and Levemir for the management of

Danish shares close lower, led down by TrygVesta, Novozymes UPDATE  -  Mar 1, 2007
Forbes,The European Commission has approved its insulin analogue Levemir for once-daily use in combination with oral anti-diabetic drugs (OADs).

In Brief  -  Mar 1, 2007
Nature.com (subscription),Its portfolio includes Levemir, a long-acting insulin; NovoLog Mix 70/30 (called NovoMix 30 outside the US), a premixed formulation of rapid-acting and

Wrongly excluded  -  Feb 16, 2007
Regina Leader-Post (subscription),Lantus (Glargine) is similar to Levemir. The provincial government does not see fit to put it on the drug plan, based on the findings of the Canadian Expert

Lilly, Novo Cut Insulin Prices for German Customers (Update1)  -  Feb 1, 2007
BloombergThe German committee will rule on long-acting analogues that work for 24 hours, including Novo Nordisk's Levemir and Sanofi's Lantus, in the next six

Danish shares close slightly higher; Danisco higher, Novo Nordisk ...  -  Jan 30, 2007
Forbes,Analysts told Boersen they expect the weaker US dollar and poor sales of Levemir insulin analogue to add to negative factors in the report and forecast.

'No conflict' in senator's forum cash  -  18 Jan 2007
The Age,...a member of the Government's policy committee on health and ageing, said: "I can't recall writing any letters (in support of Novo Nordisk's Levemir).

New Data from the Predictive Study Shows That Levemir (insulin ...  -  Dec 5, 2006
PharmaLive.com (press release),5, 2006--The long-acting modern insulin Levemir® (insulin detemir) improves blood glucose control, reduces weight and the risk of overall hypoglycaemia when

Novo says study shows Levemir reduces body weight  -  Dec 5, 2006
Reuters.uk,COPENHAGEN (Reuters) - Denmark's Novo Nordisk, the world's biggest maker of insulin, said on Tuesday a new study showed its long-acting insulin Levemir

Danish shares slightly higher midmorning, in line with Wall Street  -  Dec 18, 2006
Forbes,Daily Boersen reported this morning that US sales of Novo Nordisk's Levemir insulin analogue is under pressure because of tough competition, but Jyske Bank

Danish shares AFX market data at 9.48 am AP Moeller higher, Novo ...  -  Dec 18, 2006
Forbes,Daily Boersen reported this morning that US sales of Novo Nordisk's Levemir insulin analogue is squeezed by tough competition. However, Jyske Bank said

Novo Nordisk Up on Insulin Study Data  -  Dec 5, 2006
Forbes,Novo Nordisk AS, a Danish drug maker that specializes in insulin products, said Tuesday newly analyzed data shows that its Levemir insulin improved blood

Alitalia adds 6.4 percent  -  Dec 5, 2006
Finance Markets,Meanwhile, Novo Nordisk gained 4.3 percent to DKr464.50 on its claim that a long-acting insulin, Levemir, both helped blood sugar levels in those with

Novo Nordisk announces major expansion of its diabetes care field ...  -  Nov 30, 2006
Prdomain Business Register (press release),The field force expansion will support Novo Nordisk's complete portfolio of modern insulins (insulin analogues): Levemir®, a long-acting insulin,

ADR Report-ADRs gain on European drug makers' diabetes results  -  Dec 5, 2006
ReutersDenmark's Novo Nordisk, the world's biggest maker of insulin, said on Tuesday a new study showed its long-acting insulin Levemir also reduces body weight

Novo Nordisk expands sales force  -  Nov 30, 2006
Monsters and Critics.com,This includes Levemir, a long-acting insulin, NovoLog Mix 70/30, a premixed formulation of rapid-acting and intermediate-acting insulin, and NovoLog,

Novo Nordisk May Be Pressured By Insulin Mkt  Nov 1, 2006
Says overall, 3Q was a disappointment on the top line, with Levemir, analogues and NovoSeven sales 3%, 4% and 6% below expectations respectively. ... -newratings.com Danish shares close higher, lifted by Danske Bank, Novo Nordisk ...  Oct 31, 2006
Investors expect higher sales of the group's diabetes treatment Levemir after peer Sanofi-Aventis reported that third-quarter sales of its diabetes treatment ... -Forbes, Research and Markets: Novo Nordisk Holds a Leading Position in ...  Oct 9, 2006
...cancer and inflammation. The insulin analogues (+62 per cent), particularly Levemir, and NovoSeven (+16 per cent). Liraglutide, a ... -Business Wire (press release), Novo Nordisk: New Positive Data On Levemir, NovoRapid  Sep 15, 2006
Jones)- Danish pharmaceutical company Novo Nordisk A/S (NOVO-B.KO) on Friday presented new data which shows that its rapid-acting insulin Levemir and NovoRapid ... -Easy Bourse (Communiqués de presse)

Further PREDICTIVE™ Study Results Show Diabetes Can Be ...  Sep 17, 2006
These results show that patients switching from human insulin basal-bolus therapy to a Levemir® and NovoRapid® basal-bolus regimen benefited from1: ... -Medical News Today

Insulins added to PBS list  Aug 24, 2006
Health Minister Tony Abbott says long-lasting injectable insulins Lantus and Levemir will be subsidised from October 1, at a cost of $145 million over the next ... -Courier Mail

Diabetics to get Relief from Cheaper Drugs  Aug 25, 2006
According to Health Minister Tony Abbott long-lasting injectable insulins Levemir and Lantus will be subsidized from October 1, at a cost of $145 million over ... -MedIndia

Danish shares close higher, led up by AP Moeller-Maersk, Novo ...  Sep 6, 2006
...said. 'There have been some good sales figures in the US for its Levemir (insulin analogue product),' one broker pointed out. The ... -Forbes

On the Move:Man, Porsche, ASML  Sep 6, 2006
NOVO NORDISK (NVO) was up DKK10.00 to DKK429.50. The company's stocks outperformed on the back of solid sales results for Levemir in the US. -BusinessWeek

Long acting insulin makes the grade  Aug 28, 2006
Long acting insulin, with the two commercial names of Lantuse (insulin glargine) and Levemir@ (insulin detemir), has experienced a protracted and difficult ... -EurekAlert

AstraZeneca, Pfizer and Merck/Schering-Plough Overwhelm All ...  Aug 28, 2006
Tied for fourth most promoted were Novo Nordisk's long-acting basal insulin Levemir and Daiichi-Sankyo/Forest Pharmaceuticals' antihypertensive Benicar. ... -Business Wire

Novo says study shows Levemir reduces body weight  -  Dec 5, 2006
ReutersReuters) - Denmark's Novo Nordisk, the world's biggest maker of insulin, said on Tuesday a new study showed its long-acting insulin Levemir reduces body weight ...

New Data from the Predictive Study Shows That Levemir (insulin ...  -  Dec 5, 2006
PharmaLive.com (press release),5, 2006--The long-acting modern insulin Levemir® (insulin detemir) improves blood glucose control, reduces weight and the risk of overall hypoglycaemia when ...

Novo Nordisk Up on Insulin Study Data  -  Dec 5, 2006
Houston Chronicle,YORK — Novo Nordisk AS, a Danish drug maker that specializes in insulin products, said Tuesday newly analyzed data shows that its Levemir insulin improved ...

Novo Nordisk Announces Major Expansion of Its Diabetes Care Field ...  -  Nov 30, 2006
PharmaLive.com (press release),The field force expansion will support Novo Nordisk's complete portfolio of modern insulins (insulin analogues): Levemir®, a long-acting insulin, NovoLog ...

Lilly sees profit growth slowing ahead  -  Dec 7, 2006
CNNMoney.com...fell nearly 1 percent, while Novo Nordisk (Charts) fell about 2.5 percent a day after rising more than 3 percent on news that its Levemir insulin improved ...

Alitalia adds 6.4 percent  -  Dec 5, 2006
Finance Markets,Meanwhile, Novo Nordisk gained 4.3 percent to DKr464.50 on its claim that a long-acting insulin, Levemir, both helped blood sugar levels in those with diabetes ...

Novo Nordisk expands sales force  -  Nov 30, 2006
Monsters and Critics.com,This includes Levemir, a long-acting insulin, NovoLog Mix 70/30, a premixed formulation of rapid-acting and intermediate-acting insulin, and NovoLog, a rapid ...

India is the diabetes capital of the world with 40 million ...  -  Nov 13, 2006
Afternoon Dispatch & Courier,...available right here in the city. "There's the Flexipen, the Novorapid, Novomix and the long standing Levemir. Of course the One Touch ...

Long acting insulin makes the grade  29 Aug 2006
Long acting insulin, with the two commercial names of Lantuse (insulin glargine) and Levemir@ (insulin detemir), has experienced a protracted and difficult ... -EurekAlert

Subsidy for diabetics  Aug 24, 2006
Health Minister Tony Abbott said the long-lasting injectable insulins, Lantus and Levemir, would be included on the Pharmaceutical Benefits Scheme from October ... -Daily Telegraph

Cheap diabetes drug provides relief  Aug 24, 2006
Health Minister Tony Abbott says long-lasting injectable insulins Lantus and Levemir will be subsidised from October 1, at a cost of $145 million over the next ... -The Australian

Diabetics to get Relief from Cheaper Drugs  Aug 25, 2006
According to Health Minister Tony Abbott long-lasting injectable insulins Levemir and Lantus will be subsidized from October 1, at a cost of $145 million over ... -MedIndia

AstraZeneca, Pfizer and Merck/Schering-Plough Overwhelm All ...  Aug 28, 2006
Tied for fourth most promoted were Novo Nordisk's long-acting basal insulin Levemir and Daiichi-Sankyo/Forest Pharmaceuticals' antihypertensive Benicar. ... -Business Wire

Smells Like Legal Action  Aug 2, 2006
NEW YORK -- Fresh from a courtroom victory in June, Novo Nordisk is rolling the dice again in the justice system to defend its Levemir diabetes treatment. ... -Brandweek Magazine

Novo Nordisk second-quarter profit up 4%, lifts FY sales guidance  Aug 2, 2006
Sales of insulin analogues, including Levemir, rose 59% to DKK5.002 billion in the first six months, it said, adding that Levemir "has been well received by ... -MarketWatch

Cheaper diabetes drugs offer relief  Aug 24, 2006
Health Minister Tony Abbott said the long-lasting injectable insulins — Lantus and Levemir — would be included on the Pharmaceutical Benefits Scheme from ... -Border Mail

FDA Asks Eli Lilly To Provide Addl. Data For Arxxant Drug - Update  Aug 18, 2006
...against Sanofi-Aventis SA, in which that company sought a preliminary injunction against Novo-Nordisk's pre-launch and launch materials for Levemir, new long ... -Trading Markets

Is the market ready for a rebound?  Aug 2, 2006
...and Sanofi-Aventis SA in the $14 billion insulin market, is looking to insulin analogues to increase sales and is rolling out its latest, Levemir, in Europe. ... -GreekMoney.gr

Novo Nordisk wins Levemir 'false advertising' case against Sanofi ...  Jun 27, 2006
...a claim by Sanofi-Aventis that Novo Nordisk engaged in false advertising in pre-launch and launch materials for its new long-acting basal insulin, Levemir. ... -Forbes

Levemir Helps Patients Significantly and Safely Improve Control in ...  Jun 21, 2006
Novo Nordisk announced results from the German cohort of 10,276 patients enrolled in the observational PREDICTIVE(TM) trial, which found Levemir(R) (insulin ... -DG News

ADA: Once-Daily Dosing with Lantus and Levemir Similar for Type 2 ...  Jun 26, 2006
WASHINGTON — Long-acting insulin analogs Levemir (insulin detemir) and Lantus (insulin glargine) appear equal for once-daily usein type 2 diabetes, yet ... -MedPage Today

Novo Nordisk Prevails in Sanofi-Aventis Challenge to Levemir(R) ...  Jun 27, 2006
...in a lawsuit in which Sanofi-Aventis sought a preliminary injunction against Novo Nordisk's pre-launch and launch materials for Levemir® (insulin detemir ... -Yahoo! News

Novo Nordisk Reports Victory In Sanofi-Aventis Challenge To ...  Jun 27, 2006
...victory in a lawsuit in which Sanofi-Aventis sought a preliminary injunction against Novo Nordisk's pre-launch and launch materials for Levemir, Novo Nordisk's ... -Trading Markets

/CORRECTION -- Novo Nordisk/  Jun 27, 2006
In the news release, Novo Nordisk Prevails in Sanofi-Aventis Challenge to Levemir®, issued earlier today by Novo Nordisk over PR Newswire, we are advised by ... -Yahoo! News

Novo Nordisk Says It Prevails In Sanofi-Aventis Challenge To ...  Jun 27, 2006
SA (SNY | charts | news | PowerRating) sought a preliminary injunction against Novo Nordisk's pre-launch and launch materials for Levemir, Novo Nordisk's new ... -Trading Markets

In Diabetes Drug Suit, Judge Rules in Favor of Novo  Jun 29, 2006
...a federal court, at least, a judge has struck down a lawsuit brought by Sanofi-Aventis that sought to block a competitor’s claims about diabetes drug Levemir ... -Brandweek Magazine

Novo Nordisk Claims Win in Lawsuit  Jun 27, 2006
The lawsuit, filed in US District Court in New Jersey, alleged that Novo Nordisk falsely advertised claims about its insulin injection Levemir in both pre ... -MSN Money

Insulin Manufacturing in India: Opportunities Pouring In  Jul 7, 2006
...segment. Studying the opportunities that exist in this market Levemir, a type of basal insulin, was launched by Novo Nordisk India. ... -24-7PressRelease.com

Danish shares close higher, led up by AP Moeller-Maersk, Carlsberg ...  Jun 28, 2006
US District Court has rejected claims by Sanofi-Aventis that Novo Nordisk engaged in false advertising when launching its new long-acting basal insulin, Levemir ... -Forbes

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional